Lithuania vs Naoero: New cases tested for RR-/MDR-TB
Lithuania
100.0%
in 2024
Naoero
100.0%
in 2023
Lithuania rank
1st
Naoero rank
1st
New cases tested for RR-/MDR-TB over time
- Lithuania
- Naoero
How they compare
Lithuania currently reports 100.0% against 100.0% in Naoero, a difference of 0.0%.
The two have swapped places 1 time across 12 shared years of data; in 2009 it was Lithuania ahead.
Lithuania ranks 1st and Naoero ranks 1st of 192 countries.
Lithuania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lithuania | Naoero | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 0.0% | 100.0% | Lithuania |
| 2010s | 100.0% | 0.0% | 100.0% | Lithuania |
| 2020s | 100.0% | 75.0% | 25.0% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Lithuania or Naoero?
- Lithuania, at 100.0% against 100.0% in Naoero as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Lithuania and Naoero?
- 0.0%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Naoero?
- 12 years are reported by both, from 2009 to 2023.
- How do Lithuania and Naoero rank globally for new cases tested for rr-/mdr-tb?
- Lithuania ranks 1st and Naoero ranks 1st of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.